Resorantel is an anthelmintic drug used primarily in veterinary medicine to treat parasitic infections in animals, particularly tapeworms in ruminants. It has a broad spectrum of activity against various cestode species. The mechanism of action of resorantel involves disrupting the parasite's energy metabolism by inhibiting the enzyme succinate dehydrogenase. This enzyme plays a crucial role in the electron transport chain, which is essential for ATP production in the parasite. By inhibiting this enzyme, resorantel disrupts the parasite's energy supply, leading to its death. Resorantel is typically administered orally to animals, and it is well-absorbed from the gastrointestinal tract. It is then distributed throughout the body, reaching high concentrations in the tissues where parasites reside. Resorantel is commonly used in livestock, such as cattle, sheep, and goats, to treat tapeworm infections, which can cause significant weight loss and reduced productivity in these animals. Research on resorantel focuses on understanding its efficacy against different parasite species, optimizing its administration, and exploring potential adverse effects. It is also being investigated for its potential to treat parasitic infections in humans, though it is currently not approved for human use.'
resorantel: structure
ID Source | ID |
---|---|
PubMed CID | 65696 |
CHEMBL ID | 2105347 |
SCHEMBL ID | 1027956 |
MeSH ID | M0041000 |
Synonym |
---|
resorantel |
n-(4-bromophenyl)-2,6-dihydroxybenzamide |
FT-0655787 |
resorantelum [inn-latin] |
unii-2i8v5q9a78 |
4'-bromo-gamma-resorcylanilide |
4'-brom-2,6-dihydroxybenzanilid |
resorantel [inn] |
resorantelum |
einecs 244-040-9 |
hoe 296 v |
2i8v5q9a78 , |
benzamide, n-(4-bromophenyl)-2,6-dihydroxy- |
20788-07-2 |
A814899 |
hoe-296-v |
hoe-296 v |
CHEMBL2105347 |
AKOS015896441 |
SCHEMBL1027956 |
resorantel [mi] |
DTXSID80174879 |
sr-01000945074 |
SR-01000945074-1 |
AS-65720 |
E75929 |
sodiumbisulfide |
CCG-267556 |
Q27254786 |
resorantel 100 microg/ml in acetonitrile |
S4882 |
HY-121477 |
CS-0082168 |
Z1574812100 |
SY113738 |
mfcd00864511 |
Excerpt | Reference | Relevance |
---|---|---|
"Treatment with resorantel at 65 mg/kg or niclosamide at 50 mg/kg however, caused expulsion of the strobilae within 16--24 hours after treatment and at autopsy, lambs were free of scoleces of T." | ( The efficacy of anthelmintics against Thysaniezia giardi in South Africa. Davies, PV; Geyser, TL; RĂ©cio, M; Van Schalkwyk, PC, 1981) | 0.6 |
Excerpt | Relevance | Reference |
---|---|---|
" was tested in sheep at a dosage rate of 65 mg kg-1 live mass." | ( The anthelmintic efficacy of resorantel against cestodes in sheep. Ashburner, AJ; du Plessis, CA; Gruss, B; Malan, FS; Roper, NA, 1988) | 0.57 |
"Resorantel at a dosage rate of 130 mg kg-1 live body mass was found to be highly effective against Houttuynia struthionis in ostriches when dosed alone or in combination with fenbendazole or levamisole." | ( The anthelmintic efficacy of resorantel against Houttuynia struthionis in ostriches. Ashburner, AJ; du Plessis, C; Gruss, B; Malan, FS; Roper, NA, 1988) | 2.01 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 5 (83.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (25.52) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |